CAMBER CAPITAL MANAGEMENT LLC

Asset Manager

Founded in Hidden

  1. dHidden
  2. gHidden
  3. oHidden
  1. Headcount: Hidden
  2. Assets Under Management: Hidden

Headquarters

Point of Contact

Sequenom, Inc. (SQNM) Downgraded by Zacks Investment Research

In other news, major shareholder Camber Capital Management Llc bought 1,650,090 shares of the stock in a transaction dated Thursday, October 8th. The stock was purchased at an average price of $1.96 per share, for a total transaction of $3,234,176.40.

Read More >
storminvestor.com
December 10, 2015
Report

Report inappropriate or irrelevant content

Zacks Investment Research Downgrades Sequenom, Inc. (SQNM) to Hold

The stock currently has an average rating of “Hold” and an average price target of $1.48. In related news, major shareholder Camber Capital Management Llc acquired 1,650,090 shares of the business’s stock in a transaction that occurred on Thursday ...

Read More >
Watch List News
December 8, 2015
Report

Report inappropriate or irrelevant content

Protalix BioTherapeutics Short Interest Down 36.3% in October (PLX)

In other Protalix BioTherapeutics news, major shareholder Camber Capital Management Llc bought 4,000,423 shares of Protalix BioTherapeutics stock in a transaction on Monday, October 19th. The shares were purchased at an average cost of $1.00 per share ...

Read More >
Intercooler
November 12, 2015
Report

Report inappropriate or irrelevant content

Ariad Pharmaceuticals sets ‘poison pill’ provision

Boston-based hedge fund Camber Capital Management LLC, which focuses on health care, also disclosed a stake of 10 million shares, or 5.4 percent, on Oct. 23, none of which was owned as recently as June 30, according to regulatory filings. Ariad also said ...

Read More >
The Boston Globe
November 2, 2013
Report

Report inappropriate or irrelevant content

Protalix BioTherapeutics Inc. (PLX) Short Interest Down 5.0% in November

In other Protalix BioTherapeutics news, major shareholder Camber Capital Management Llc bought 4,000,423 shares of the stock in a transaction on Monday, October 19th. The shares were bought at an average price of $1.00 per share, with a total value of $ ...

Read More >
Ticker Report
December 10, 2015
Report

Report inappropriate or irrelevant content

BIOLASE To Raise $35 Million From Institutional And Individual Investors In Private Placement

Schuler, Oracle Partners, L.P. and other Oracle funds, three funds managed by Camber Capital Management, LLC, Eagle Growth Partners I and II, Birchview Capital L.P., Trellus Partners, LP, CAC, LLC, and certain BIOLASE directors, officers, and employees ...

Read More >
The Street
November 4, 2014
Report

Report inappropriate or irrelevant content

Company Overview of Camber Capital Management LLC

Camber Capital Management LLC is a privately owned hedge fund sponsor. The firm primarily provides its services to pooled investment vehicles. It also manages accounts for individuals. The firm invests in the public equity and hedging markets of the United ...

Read More >
Bloomberg
July 1, 2015
Report

Report inappropriate or irrelevant content

Form SC 13G/A AMARIN CORP PLC Filed by: Camber Capital Management LLC

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided ...

Read More >
StreetInsider
February 13, 2015
Report

Report inappropriate or irrelevant content

Camber Capital Says Volcano Shares Are Undervalued

Camber Capital Management LLC said Thursday that shares in Volcano Corp. are undervalued and that it may seek discussions with the company's management over potential business combinations and strategic alternatives. Shares of the company rose 4% in early ...

Read More >
Wall Street Journal
October 2, 2014
Report

Report inappropriate or irrelevant content

Biolase Announces $5M Stock Sale, Shares Up

The laser maker’s shares were up 12% to a market value of about $71 million at midday. Biolase said in a release that Boston-based Camber Capital Management LLC would buy 2,688,172 shares of the company at $1.86 a share, which is equal to yesterday’s ...

Read More >
Orange County Business Journal
September 24, 2013
Report

Report inappropriate or irrelevant content

O.C. Prudential offices join Buffett's chain

New and repeat investors accounted for the other half of the sales. Biolase Inc., an Irvine-based dental laser maker, announced that Camber Capital Management LLC has agreed to purchase 2.7million shares of its stock, for a total investment of $5million.

Read More >
Orange County Register
September 25, 2013
Report

Report inappropriate or irrelevant content

Ariad Pharma adopts poison pill measure

Boston-based hedge fund Camber Capital Management LLC, which focuses on healthcare, also disclosed a stake of 10 million shares, or 5.4 percent, on Oct. 23, none of which was owned as recently as June 30, according to regulatory filings. Ariad also said it ...

Read More >
Yahoo Finance
November 1, 2013
Report

Report inappropriate or irrelevant content

Biolase Gets $35M In Private Placement

Schuler, Oracle Partners, L.P. and other Oracle funds, three funds managed by Camber Capital Management, LLC, Eagle Growth Partners I and II, Birchview Capital L.P., Trellus Partners, as well as its directors, officers, and employees. The company said it ...

Read More >
SOCALTECH
November 5, 2014
Report

Report inappropriate or irrelevant content

Bayer to buy Conceptus for $1.1B

The target's shares have risen by about a third in the past year. Last March activist shareholder Camber Capital Management LLC bought a 3.2% Conceptus stake. Camber urged Conceptus to consider its strategic options. Bayer shares traded €0.09 lower in ...

Read More >
The Deal Pipeline
April 30, 2013
Report

Report inappropriate or irrelevant content

HCA Holdings Held By Latest 13F Filers

Worth noting is that 40 North Management LLC, Camber Capital Management LLC, Consulta Ltd, and PointState Capital LP, included in this recent batch of 13F filers, exited HCA common stock as of 09/30/2014. Looking beyond these particular funds in this one ...

Read More >
Forbes
November 17, 2014
Report

Report inappropriate or irrelevant content

Ariad Pharmaceuticals sets ‘poison pill’ provision

Boston-based hedge fund Camber Capital Management LLC, which focuses on health care, also disclosed a stake of 10 million shares, or 5.4 percent, on Oct. 23, none of which was owned as recently as June 30, according to regulatory filings. Ariad also said ...

Read More >
The Boston Globe
November 1, 2013
Report

Report inappropriate or irrelevant content

Will Small Cap Dental Stock BIOLASE Inc (BIOL) Reward Investors Even More? SIRO, XRAY & ALGN

Camber Capital Management, LLC. That offering at a share price of $1.86 per share resulted in gross proceeds of $5 million. On Monday, small cap BIOLASE Inc surged 17.69% to $3.06 (BIOL has a 52 week trading range of $1.15 to $5.96 a share) for a market ...

Read More >
Smallcap Network
December 31, 2013
Report

Report inappropriate or irrelevant content

How High Will Bluebird Bio Fly?

Top institutional holders of bluebird bio stock are Ameriprise Financial Inc., Camber Capital Management, LLC, and Citadel Advisors LLC. Top mutual fund holders are Fidelity Contrafund, Prudential Jennison Health Sciences Fund, American Funds Insurance Ser ...

Read More >
Seeking Alpha
September 12, 2013
Report

Report inappropriate or irrelevant content

Biolase to raise $35 million from institutional and individual investors in private placement

These investors include: Jack W. Schuler; Oracle Partners LP and other Oracle funds; three funds managed by Camber Capital Management LLC; Eagle Growth Partners I and II; Birchview Capital LP; Trellus Partners LP, CAC, LLC; and certain Biolase directors ...

Read More >
Dentistry IQ
November 5, 2014
Report

Report inappropriate or irrelevant content

CAMBER CAPITAL MANAGEMENT LLC

8:35PM ET - Dow Jones Business News Apple Escalates Ad-Blockers Fight 8:35PM ET - Dow Jones Business News Facebook Adds Tool to Detect Unauthorized Posts of Video 8:35PM ET - Dow Jones Business News Lawyer''s Offstage Acts Threaten Record Pact 8:06PM ET ...

Read More >
NASDAQ
June 29, 2015
Report

Report inappropriate or irrelevant content

Key Executives for Camber Capital Management LLC

To contact Camber Capital Management LLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Read More >
Bloomberg
August 26, 2015
Report

Report inappropriate or irrelevant content

Malcolm Mackey Named to 2012 ACC Tournament Legends Team

Greensboro, N.C. - Malcolm Mackey, Georgia Tech's all-time leading rebounder and a member ... he is now the Head of Investor Relations with Camber Capital Management LLC and lives in the Boston, Mass. area. Solomon (1978-82), one of the best basketball ...

Read More >
Ramblin Wreck
February 8, 2012
Report

Report inappropriate or irrelevant content

Protalix BioTherapeutics Stock Rating Upgraded by Zacks (PLX)

In related news, major shareholder Camber Capital Management Llc bought 4,000,423 shares of the company’s stock in a transaction on Monday, October 19th. The stock was bought at an average cost of $1.00 per share, for a total transaction of $4,000,423.00.

Read More >
wkrb13.com
October 27, 2015
Report

Report inappropriate or irrelevant content

Protalix BioTherapeutics Upgraded at Zacks (PLX)

In other news, major shareholder Camber Capital Management Llc bought 4,000,423 shares of Protalix BioTherapeutics stock in a transaction dated Monday, October 19th. The shares were acquired at an average cost of $1.00 per share, with a total value of $ ...

Read More >
Ticker Report
October 30, 2015
Report

Report inappropriate or irrelevant content

Sequenom major shareholder Camber Capital Management Llc Buys 1,650,090 Shares (SQNM)

Sequenom (NASDAQ:SQNM) major shareholder Camber Capital Management Llc acquired 1,650,090 shares of Sequenom stock in a transaction on Thursday, October 8th. The shares were bought at an average price of $1.96 per share, for a total transaction of $ ...

Read More >
sleekmoney.com
October 11, 2015
Report

Report inappropriate or irrelevant content

Filing Details

Securities reported herein for Camber Capital Management LLC (the "LLC" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Fund"), another private investment fund (the "Fund") and one managed account ...

Read More >
INSIDER MONKEY
October 20, 2015
Report

Report inappropriate or irrelevant content

Insiders Buy Stock in Wynn Resorts, Bank of New York Mellon

On Oct. 19, Camber Capital Management LLC, a 10% owner of Protalix Bio Therapeutics Inc. (PLX) bought 4,000,423 shares of the company at the price of $1.00 per share and a total cost of $4,000,420. Since then the price of the stock has risen by 12%.

Read More >
Guru Focus
October 26, 2015
Report

Report inappropriate or irrelevant content

Insiders Are Selling Dave & Buster's Entertainment and Buying Twinlab

Since then, the price of the stock has risen by 8.60%. On Oct. 10, Camber Capital Management LLC, 10% owner of Sequenom Inc. ( SQNM), bought 1,650,090 shares of the company at the average price of $1.96 and a total cost of $3,234,180. Since then ...

Read More >
NASDAQ
October 9, 2015
Report

Report inappropriate or irrelevant content

Sequenom Receives Consensus Recommendation of “Hold” from Brokerages (NASDAQ:SQNM)

Analysts predict that Sequenom will post ($0.30) EPS for the current fiscal year. In other Sequenom news, major shareholder Camber Capital Management Llc bought 1,650,090 shares of the firm’s stock in a transaction dated Thursday, October 8th.

Read More >
DC Progressive
October 27, 2015
Report

Report inappropriate or irrelevant content

Stephen Rodney Du Bois

Mr. Stephen Rodney Du Bois, also known as Steve is the Founder at Camber Capital Management LLC. He is a managing member of the firm. To contact Camber Capital Management LLC, please visit . Company data is provided by Capital IQ. Please use this form to ...

Read More >
Bloomberg
October 24, 2015
Report

Report inappropriate or irrelevant content

No news for CAMBER CAPITAL MANAGEMENT LLC right now. Check back soon!
Powered by
Loading...
Loading...